Common allergy pill could shield cancer patients from Chemo's painful side effect
NCT ID NCT07109817
Summary
This study is testing if desloratadine, a common and safe allergy medication, can prevent or reduce nerve pain and damage (peripheral neuropathy) caused by taxane chemotherapy in people with breast cancer. About 116 participants will be randomly assigned to receive either the drug or a placebo (a look-alike pill with no medicine) while undergoing their chemotherapy. Researchers will use questionnaires to measure nerve symptoms and quality of life to see if the allergy pill helps.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Montefiore Medical Center
The Bronx, New York, 10467, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.